Holdings of TANG CAPITAL MANAGEMENT LLC
46 declared positions · as of Mar 31, 2026
Original filing · Ten largest lines: 62.1 % of the equity sleeve
Sector breakdown
- Health care 3.3 %
- Unattributed 96.7 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
The quoted currency of each line, as declared.
Country breakdown
- US 89.2 %
- BE 6.9 %
- DE 2.5 %
- GB 1.3 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|
| 1 | US | 43 | 1.5B $ | 89.22 % |
| 2 | BE | 1 | 113.6M $ | 6.90 % |
| 3 | DE | 1 | 41.8M $ | 2.54 % |
| 4 | GB | 1 | 22.1M $ | 1.34 % |
Positions
| Rank | Company | Shares | Value | Weight |
|---|
| 1 | Celcuity Inc | 1,050,000 | 119.8M $ | |
| 2 | Mirum Pharmaceuticals Inc | 1,236,027 | 114.2M $ | |
| 3 | Galapagos NV | 3,785,991 | 113.6M $ | |
| 4 | State Street SPDR S&P 500 ETF Trust | 168,000 | 109.3M $ | |
| 5 | Capricor Therapeutics Inc | 3,399,900 | 103.4M $ | |
| 6 | PTC Therapeutics Inc | 1,500,000 | 102.2M $ | |
| 7 | Spyre Therapeutics Inc | 1,892,200 | 95.4M $ | |
| 8 | KalVista Pharmaceuticals Inc | 4,573,530 | 92.1M $ | |
| 9 | Compass Therapeutics Inc | 16,790,809 | 88.8M $ | |
| 10 | Tarsus Pharmaceuticals Inc | 1,188,624 | 83.4M $ | |
| 11 | Immunocore Holdings PLC | 2,649,368 | 79.9M $ | |
| 12 | AnaptysBio Inc | 1,330,879 | 73.8M $ | |
| 13 | Corcept Therapeutics Inc | 1,500,000 | 60.5M $ | |
| 14 | ANI Pharmaceuticals Inc | 707,500 | 54.4M $ | |
| 15 | Insmed Inc | 260,000 | 42.5M $ | |
| 16 | BioNTech SE | 470,000 | 41.8M $ | |
| 17 | Viridian Therapeutics Inc | 1,792,626 | 35.1M $ | |
| 18 | Atea Pharmaceuticals Inc | 4,814,700 | 25.9M $ | |
| 19 | Precigen Inc | 6,417,500 | 24.8M $ | |
| 20 | Dianthus Therapeutics Inc | 264,692 | 22.2M $ | |
| 21 | Compass Pathways plc | 4,002,200 | 22.1M $ | |
| 22 | Stoke Therapeutics Inc | 500,000 | 16.3M $ | |
| 23 | Viking Therapeutics Inc | 500,000 | 16.3M $ | |
| 24 | Ideaya Biosciences Inc | 450,000 | 15M $ | |
| 25 | Nuvation Bio Inc | 3,149,557 | 13.5M $ | |
| 26 | Pliant Therapeutics Inc | 6,143,132 | 7.7M $ | |
| 27 | Journey Medical Corp | 1,610,000 | 7.6M $ | |
| 28 | Janux Therapeutics Inc | 500,000 | 7M $ | |
| 29 | Biogen Inc | 35,000 | 6.4M $ | |
| 30 | Arvinas Inc | 538,658 | 5.7M $ | |
| 31 | PMV Pharmaceuticals Inc | 4,245,085 | 5.3M $ | |
| 32 | Moderna Inc | 100,000 | 5.1M $ | |
| 33 | Heron Therapeutics Inc | 6,250,000 | 5M $ | |
| 34 | Kezar Life Sciences Inc | 664,314 | 4.9M $ | |
| 35 | LENZ Therapeutics Inc | 451,114 | 4.1M $ | |
| 36 | Agios Pharmaceuticals Inc | 100,000 | 3.4M $ | |
| 37 | Erasca Inc | 200,000 | 3.2M $ | |
| 38 | Coherus Oncology Inc | 1,886,748 | 3.2M $ | |
| 39 | Nkarta Inc | 1,480,823 | 3.1M $ | |
| 40 | Altimmune Inc | 666,022 | 2.1M $ | |
| 41 | Evolus Inc | 483,021 | 2M $ | |
| 42 | Abeona Therapeutics Inc | 400,000 | 1.8M $ | |
| 43 | Fate Therapeutics Inc | 1,167,773 | 1.4M $ | |
| 44 | Neumora Therapeutics Inc | 439,878 | 857.8K $ | |
| 45 | LEXICON PHARMACEUTICALS INC | 399,700 | 623.5K $ | |
| 46 | Rocket Pharmaceuticals Inc | 100,000 | 358K $ | |